Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: Lane3 who wrote (197755)	4/2/2021 6:04:56 PM
From: i-node	Respond to of 356238

>> My only point was that four times the fatal amount intuitively seemed like a wild exaggeration to me. It stuck out. Had you said twice, I would not have blinked. I'm no pharmacologist but I would just say there is a dramatic difference between fentanyl and e.g., buprenorphine (suboxone) which has a dramatically longer half life (as much as 10x difference). I would expect something with a short half-life to have a brief but substantial spike in potency. Whereas suboxone (used for pain management and as a safer alternative for addicts in trying to prevent death due to overdose).